AI screening for heart failure in pacemaker patients
Part of Heart & circulation clinical trials.
This trial uses artificial intelligence to screen pacemaker patients for early signs of heart failure. It is designed for people who have a standard pacemaker, do not already have heart failure, and have a high amount of right ventricular pacing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a pacemaker that paces the right ventricle at least 20% of the time.
- You have never been diagnosed with heart failure.
- Your heart's pumping strength (left ventricular ejection fraction) has never been below 50%.
- You do not have a special 'conduction system' pacemaker, a CRT device, an ICD, or a leadless pacemaker.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses artificial intelligence (AI) to look at records from people who have pacemakers or similar heart devices. The goal is to learn how to predict risks and improve future care for people with these devices.
This trial uses an artificial intelligence system to analyze electrocardiograms (ECGs, which are recordings of your heart's electrical activity) to detect heart failure early. It is for people over 65 who either have symptoms that might be heart failure or have risk factors for heart failure but no current symptoms.
This study tests whether artificial intelligence (AI) can analyze heart signals from a standard 12-lead ECG and a simpler 1-lead ECG. Participants will have an extra ECG taken during their regular visit, which takes just a few extra minutes and helps doctors learn if AI can spot heart issues from a simpler test.
This study uses artificial intelligence (AI) to look at your heart tests (ECG and echo) and find people who might have a specific heart muscle disease called ATTR-CM. The goal is to catch it earlier so treatment can start sooner.
This trial uses an AI tool to analyze your ECG (heart tracing) to detect low pumping function. It may help find hidden heart issues early, especially if you haven't had a recent heart ultrasound.
This trial tests whether using an artificial-intelligence (AI) tool during a heart ultrasound can help guide care for people at risk for heart problems. You might benefit if you have symptoms with exercise or heart risk factors, but you do not already have known heart failure or major heart disease.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.